ZIMMER BIOMET HOLDINGS, INC. (ZBH) Current Ratio
- Current ratio · latest quarter: Value 1.69×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.69× | Current assets / current liabilities. $5.10B ÷ $3.01B ≈ 1.69× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 5.10B USD | Assets, Current |
| Current obligations | 3.01B USD | Liabilities, Current |
| Cash and equivalents | 410.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 1.77B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 2.27B USD | Inventory, Net |
| Payables | 352.40M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 1.20B USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.10B | $3.01B | $410.00M | (m) | $1.77B | $2.27B | $352.40M | $1.20B | 1.69× |
| 2026-03-31 | $4.96B | $2.86B | $424.20M | (m) | $1.73B | $2.25B | $361.20M | $1.18B | 1.73× |
| 2025-12-31 | $5.12B | $2.58B | $591.90M | (m) | $1.70B | $2.29B | $303.00M | $587.10M | 1.98× |
| 2025-09-30 | $5.83B | $2.40B | $1.29B | (m) | $1.60B | $2.48B | $315.30M | $600.00M | 2.43× |
| 2025-06-30 | $5.05B | $2.70B | $556.90M | (m) | $1.61B | $2.45B | $348.70M | $820.00M | 1.87× |
| 2025-03-31 | $5.59B | $2.29B | $1.38B | (m) | $1.53B | $2.24B | $301.30M | $600.00M | 2.44× |
| 2024-12-31 | $4.67B | $2.45B | $525.50M | (m) | $1.48B | $2.24B | $194.60M | $863.00M | 1.91× |
| 2024-09-30 | $4.86B | $3.57B | $569.00M | (m) | $1.48B | $2.37B | $322.40M | $1.71B | 1.36× |
| 2024-06-30 | $4.64B | $3.61B | $420.10M | (m) | $1.42B | $2.37B | $341.80M | $1.88B | 1.29× |
| 2024-03-31 | $4.63B | $2.80B | $393.00M | (m) | $1.45B | $2.39B | $370.30M | $970.00M | 1.66× |
| 2023-12-31 | $4.61B | $2.86B | $415.80M | (m) | $1.44B | $2.39B | $410.60M | $900.00M | 1.61× |
| 2023-09-30 | $4.37B | $2.07B | $292.10M | (m) | $1.34B | $2.32B | $319.70M | $355.00M | 2.11× |
| 2023-06-30 | $4.39B | $2.23B | $319.80M | (m) | $1.37B | $2.28B | $354.60M | $520.00M | 1.96× |
| 2023-03-31 | $4.41B | $2.34B | $330.20M | (m) | $1.38B | $2.24B | $397.10M | $585.00M | 1.89× |
| 2022-12-31 | $4.43B | $2.36B | $375.70M | (m) | $1.38B | $2.15B | $354.10M | $544.30M | 1.88× |
| 2022-09-30 | $4.53B | $2.30B | $545.40M | (m) | $1.28B | $2.13B | $333.90M | $659.10M | 1.98× |
| 2022-06-30 | $4.46B | $2.46B | $386.40M | (m) | $1.28B | $2.12B | $307.10M | $851.90M | 1.81× |
| 2022-03-31 | $4.52B | $2.67B | $435.80M | (m) | $1.25B | $2.13B | $322.00M | $1.01B | 1.69× |
| 2021-12-31 | $4.88B | $3.47B | $378.10M | (m) | $1.26B | $2.15B | $306.50M | $1.61B | 1.41× |
| 2021-09-30 | $5.31B | $2.94B | $919.60M | (m) | $1.39B | $2.52B | $327.60M | $1.05B | 1.81× |
| 2021-06-30 | $5.36B | $2.93B | $1.04B | (m) | $1.42B | $2.53B | $360.60M | $1.05B | 1.83× |
| 2021-03-31 | $5.00B | $2.09B | $724.30M | (m) | $1.38B | $2.51B | $329.80M | $300.00M | 2.39× |
| 2020-12-31 | $5.08B | $2.56B | $774.70M | (m) | $1.28B | $2.17B | $281.90M | $500.00M | 1.99× |
| 2020-09-30 | $5.15B | $2.27B | $967.30M | (m) | $1.34B | $2.49B | $334.80M | $450.00M | 2.27× |
| 2020-06-30 | $4.71B | $2.16B | $713.40M | (m) | $1.06B | $2.50B | $363.40M | $450.00M | 2.18× |
| 2020-03-31 | $6.37B | $3.78B | $2.43B | (m) | $1.04B | $2.46B | $404.90M | $1.95B | 1.69× |
| 2019-12-31 | $4.72B | $3.44B | $617.90M | (m) | $1.36B | $2.38B | $400.90M | $1.50B | 1.37× |
| 2019-09-30 | $4.40B | $3.77B | $512.50M | (m) | $1.15B | $2.36B | $355.20M | $2.00B | 1.17× |
| 2019-06-30 | $4.39B | $3.68B | $403.10M | (m) | $1.25B | $2.34B | $347.50M | $2.00B | 1.19× |
| 2019-03-31 | $4.50B | $2.25B | $586.80M | (m) | $1.23B | $2.31B | $361.10M | $500.00M | 2.00× |
| 2018-12-31 | $4.43B | $2.42B | $542.80M | (m) | $1.28B | $2.26B | $362.60M | $525.00M | 1.83× |
| 2018-09-30 | $4.51B | $2.39B | $524.60M | (m) | $1.26B | $2.22B | $345.80M | $600.00M | 1.89× |
| 2018-06-30 | $4.48B | $1.85B | $481.20M | (m) | $1.34B | $2.16B | $355.70M | $100.00M | 2.41× |
| 2018-03-31 | $5.78B | $3.42B | $1.77B | (m) | $1.42B | $2.13B | $347.30M | $1.63B | 1.69× |
| 2017-12-31 | $4.56B | $3.07B | $524.40M | (m) | $1.54B | $2.07B | $330.20M | $1.23B | 1.49× |
| 2017-09-30 | $4.43B | $3.01B | $480.80M | (m) | $1.32B | $2.08B | $327.10M | $1.23B | 1.47× |
| 2017-06-30 | $4.42B | $3.00B | $450.00M | (m) | $1.42B | $2.02B | $360.20M | $1.33B | 1.48× |
| 2017-03-31 | $5.08B | $2.66B | $1.04B | (m) | $1.60B | $1.98B | $335.90M | $975.00M | 1.91× |
| 2016-12-31 | $4.66B | $2.38B | $634.10M | (m) | $1.60B | $1.96B | $364.50M | $575.60M | 1.96× |
| 2016-09-30 | $4.70B | $2.31B | $475.30M | $13.40M | $1.60B | $2.07B | $266.30M | $575.80M | 2.03× |
| 2016-06-30 | $5.05B | $2.10B | $976.30M | (m) | $1.59B | $1.96B | $243.80M | $500.00M | 2.40× |
| 2016-03-31 | $5.08B | $1.51B | $996.80M | $13.40M | $1.57B | $2.08B | $252.60M | (m) | 3.36× |
| 2015-12-31 | $5.85B | $1.62B | $1.46B | $164.60M | $1.45B | $2.25B | $284.80M | (m) | 3.62× |
| 2015-09-30 | $6.39B | $1.79B | $1.47B | $343.30M | $1.39B | $2.36B | $223.60M | $225.00M | 3.58× |
| 2015-06-30 | $6.75B | $2.15B | (m) | (m) | (m) | $2.44B | $242.50M | (m) | 3.15× |
| 2015-03-31 | $11.94B | $893.50M | (m) | (m) | (m) | $1.24B | $151.10M | (m) | 13.36× |
| 2014-12-31 | $4.31B | $1.02B | $1.08B | $612.50M | $912.10M | $1.19B | $145.20M | (m) | 4.21× |
| 2014-09-30 | $4.33B | $1.09B | $967.30M | $779.80M | $947.60M | $1.18B | $149.10M | (m) | 3.96× |
| 2014-06-30 | $4.23B | $952.90M | $968.70M | $729.30M | $950.20M | $1.15B | $171.80M | (m) | 4.44× |
| 2014-03-31 | $4.05B | $918.70M | $882.70M | $705.40M | $939.10M | $1.13B | $155.30M | (m) | 4.40× |
| 2013-12-31 | $4.20B | $1.03B | $1.08B | $727.00M | $936.60M | $1.07B | $146.30M | (m) | 4.07× |
| 2013-09-30 | $3.84B | $804.20M | $917.40M | $588.40M | $898.90M | $1.08B | $146.60M | (m) | 4.77× |
| 2013-06-30 | $3.59B | $804.30M | $709.90M | $525.90M | $942.50M | $1.05B | $165.20M | (m) | 4.47× |
| 2013-03-31 | $3.46B | $763.30M | $657.00M | $544.20M | $912.50M | $1.04B | $174.30M | (m) | 4.54× |
| 2012-12-31 | $3.71B | $866.00M | $884.30M | $671.60M | $884.60M | $995.30M | $184.10M | (m) | 4.28× |
| 2012-09-30 | $3.63B | $755.50M | $801.50M | $687.40M | $874.90M | $994.10M | $141.10M | (m) | 4.81× |
| 2012-06-30 | $3.48B | $683.10M | $651.00M | $684.90M | $906.70M | $956.00M | $137.20M | (m) | 5.09× |
| 2012-03-31 | $3.32B | $861.80M | $674.00M | $555.10M | $895.00M | $937.00M | $126.00M | (m) | 3.86× |
| 2011-12-31 | $3.28B | $867.10M | $768.30M | $455.50M | $838.80M | $929.80M | $143.30M | (m) | 3.78× |
| 2011-09-30 | $3.07B | $674.60M | $553.00M | $424.90M | $827.90M | $968.40M | $108.60M | (m) | 4.56× |
| 2011-06-30 | $3.11B | $679.00M | $624.10M | $321.40M | $888.40M | $975.10M | $124.00M | (m) | 4.58× |
| 2011-03-31 | $3.03B | $713.40M | $575.60M | $290.60M | $876.30M | $958.40M | $127.30M | (m) | 4.25× |
| 2010-12-31 | $3.01B | $702.50M | $668.90M | $265.10M | $775.90M | $936.40M | $129.60M | (m) | 4.28× |
| 2010-09-30 | $3.01B | $698.60M | $918.60M | $63.00M | $757.80M | $925.40M | $116.50M | (m) | 4.30× |
| 2010-06-30 | $2.98B | $601.80M | $953.70M | (m) | $765.10M | $885.80M | $115.00M | (m) | 4.96× |
| 2010-03-31 | $2.87B | $655.20M | $821.20M | (m) | $767.10M | $896.50M | $136.00M | (m) | 4.39× |
| 2009-12-31 | $2.74B | $690.70M | $691.70M | $66.40M | $751.40M | $913.20M | $134.60M | (m) | 3.96× |
| 2009-09-30 | $2.45B | $676.70M | $439.70M | (m) | $743.20M | $972.10M | $121.00M | (m) | 3.62× |
| 2009-06-30 | $2.33B | $669.20M | $277.50M | (m) | $768.70M | $980.90M | $144.00M | (m) | 3.48× |
| 2008-12-31 | $2.18B | $771.10M | $212.60M | (m) | $732.80M | $928.30M | $186.40M | (m) | 2.83× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |